Literature DB >> 19171835

Vascular risk factors and dementia: how to move forward?

Anand Viswanathan1, Walter A Rocca, Christophe Tzourio.   

Abstract

In recent years, accumulating evidence has suggested that vascular risk factors contribute to Alzheimer disease (AD). Vascular dementia had been traditionally considered secondary to stroke and vascular disease. It has been traditionally distinguished from AD, considered to be a purely neurodegenerative form of dementia. However, in light of this more recent literature, it appears that there is a spectrum: ranging from patients with pure vascular dementia to patients with pure AD and including a large majority of patients with contributions from both Alzheimer and vascular pathologies. In this article, we discuss the impact of vascular risk factors on AD and its consequences at the individual level and at the population level by highlighting the concept of attributable risk. We then discuss the key questions and next steps involved in designing a therapeutic trial to control vascular risk factors for the prevention of dementia.

Entities:  

Mesh:

Year:  2009        PMID: 19171835      PMCID: PMC2677504          DOI: 10.1212/01.wnl.0000341271.90478.8e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  54 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

Review 2.  Cerebral microhemorrhage.

Authors:  Anand Viswanathan; Hugues Chabriat
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

3.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

4.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

5.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

8.  Dementia after stroke: the Framingham Study.

Authors:  Cristina S Ivan; Sudha Seshadri; Alexa Beiser; Rhoda Au; Carlos S Kase; Margaret Kelly-Hayes; Philip A Wolf
Journal:  Stroke       Date:  2004-04-29       Impact factor: 7.914

9.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  A Heyman; G G Fillenbaum; K A Welsh-Bohmer; M Gearing; S S Mirra; R C Mohs; B L Peterson; C F Pieper
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  133 in total

Review 1.  Dietary fatty acids and the aging brain.

Authors:  Greg M Cole; Qiu-Lan Ma; Sally A Frautschy
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

2.  A brief update on dementia prevention.

Authors:  M C Polidori; L Pientka
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

3.  HDL Cholesterol Is Independently Associated with Cognitive Function in Males But Not in Females within a Cohort of Nonagenarians: The MUGELLO Study.

Authors:  S Pancani; F Sofi; F Cecchi; C Macchi
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

4.  Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging.

Authors:  W Chen; X Song; Y Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

5.  Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

Authors:  T M Polvikoski; E C W van Straaten; F Barkhof; R Sulkava; H J Aronen; L Niinistö; M Oinas; P Scheltens; T Erkinjuntti; R N Kalaria
Journal:  Neurology       Date:  2010-11-03       Impact factor: 9.910

Review 6.  DHA may prevent age-related dementia.

Authors:  Greg M Cole; Sally A Frautschy
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

Review 7.  Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.

Authors:  Ryan G Soderquist; Melissa J Mahoney
Journal:  Expert Opin Drug Deliv       Date:  2010-03       Impact factor: 6.648

8.  Depressive Symptoms and Longitudinal Changes in Cognition: Women's Health Initiative Study of Cognitive Aging.

Authors:  Joseph S Goveas; Mark A Espeland; Patricia E Hogan; Hilary A Tindle; Regina A Shih; Jane M Kotchen; Jennifer G Robinson; Deborah E Barnes; Susan M Resnick
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-02-28       Impact factor: 2.680

9.  Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel.

Authors:  S D Israeli-Korn; M Masarwa; E Schechtman; A Abuful; R Strugatsky; S Avni; L A Farrer; R P Friedland; R Inzelberg
Journal:  Neuroepidemiology       Date:  2009-12-11       Impact factor: 3.282

10.  Paeoniflorin improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia.

Authors:  Li-Gong Zhang; Li-Jun Wang; Qing-Qing Shen; Hao-Feng Wang; Ying Zhang; Cui-Ge Shi; Shu-Cheng Zhang; Meng-Yuan Zhang
Journal:  Chin J Integr Med       Date:  2015-11-17       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.